← Back to Search

Photobiomodulation

Real LED Intervention for Traumatic Brain Injury

Phase < 1
Waitlist Available
Led By Paula I Martin, PhD
Research Sponsored by Boston VA Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from 1-week to 1-month after series

Summary

This trial is exploring whether an at-home light therapy using a head frame device can help improve thinking and memory in people with mild to moderate traumatic brain injury. The therapy involves using the device for 20 minutes, 3 times a week, for 5 weeks, with a one-month break in between. There will be 4 office visits for paper and pencil testing, and 3 office visits for MRI scans. The trial will last for about 4 months.

Eligible Conditions
  • Traumatic Brain Injury
  • Cognitive Impairment
  • Head Injuries

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from 1-week to 1-month after series
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 1-week to 1-month after series for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CVLT-II, Long Delay Free Recall 1
CVLT-II, Long Delay Free Recall 2
CVLT-II, Long Delay Free Recall 3
+1 more
Secondary study objectives
Beck Depression Inventory (BDI) 1
Beck Depression Inventory (BDI) 2
Beck Depression Inventory (BDI) 3
+85 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Real LED InterventionActive Control1 Intervention
Participants receive 15 Real (active) LED treatments with the Vielight Neuro Alpha head frame device (with intranasal). Parameters: NIR, 810nm, pulsed at 10 Hz, 50% duty cycle, synchronized for a 20-minute treatment time. Total Energy Dose per head set plus intranasal: 225 J/cm2+ 15 J/cm2 = 240 J/cm2 per 20 min LED treatment. Total Energy Dose delivered (3x/Week, 5 Weeks) = 3600 J/cm2. The light from these LEDs is not visible to the eye. There is no potential for eye damage because the LEDs are not laser light. The head frame device falls within the FDA category General Wellness, low-risk devices, and no medical claims are made. It is approved for use by the VA Boston Healthcare System Safety Committee and Institutional Review Board.
Group II: Sham LED InterventionPlacebo Group2 Interventions
Participants receive a series of 15 Sham (control) LED treatments with the Vielight Neuro Alpha head frame device (with intranasal) containing Sham LEDs, synchronized for a 20-minute treatment time (3x/Week, 5 Weeks). Sham and Real devices are identical in look and feel, except no photons are emitted from the Sham devices.

Find a Location

Who is running the clinical trial?

Boston VA Research Institute, Inc.Lead Sponsor
23 Previous Clinical Trials
10,826 Total Patients Enrolled
VA Boston Healthcare SystemFED
70 Previous Clinical Trials
970,538 Total Patients Enrolled
Vielight Inc.Industry Sponsor
4 Previous Clinical Trials
619 Total Patients Enrolled

Media Library

Real LED Intervention (Photobiomodulation) Clinical Trial Eligibility Overview. Trial Name: NCT04230577 — Phase < 1
Traumatic Brain Injury Research Study Groups: Real LED Intervention, Sham LED Intervention
Traumatic Brain Injury Clinical Trial 2023: Real LED Intervention Highlights & Side Effects. Trial Name: NCT04230577 — Phase < 1
Real LED Intervention (Photobiomodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04230577 — Phase < 1
~3 spots leftby Nov 2025